Search Results1-20 of  20

  • 脇坂 明美 ID: 9000003752388

    北大第一病理 (1979 from CiNii)

    Articles in CiNii:3

    • 6.アトピー素因の免疫学的背景 : アトピー家系のHL-A typing(<ワークショップ>3 HL-A抗原と免疫遺伝学) (1975)
    • 3) A case of myotonic dystrophy. : Hokkaido Regional Meeting 35 (1979)
    • 12) 体外式ペースメーカーで救命し得たリウマチ性心筋炎の一例 : 第32回日本循環器学会北海道地方会 (1977)
  • 脇坂 明美 ID: 9000008823503

    Articles in CiNii:2

    • 難病とHLA,日本の現況 (HLAと疾病--難病の免疫遺伝学的アプロ-チ) (1982)
    • HLA検査の方法論--HLA-D (HLAと疾病--難病の免疫遺伝学的アプロ-チ) -- (HLA検査の方法論) (1982)
  • 脇坂 明美 ID: 9000020423249

    北海道大病理学第1講座 (1994 from CiNii)

    Articles in CiNii:1

    • 内在性レトロウイルスと免疫疾患 (1994)
  • 脇坂 明美 ID: 9000020558116

    北海道大学第1病理 (1981 from CiNii)

    Articles in CiNii:1

    • 難病とHLA (1981)
  • 脇坂 明美 ID: 9000020578351

    北海道大学第1病理 (1991 from CiNii)

    Articles in CiNii:1

    • Hereditary factor of insulin-dependent diabetes mellitus. (1991)
  • 脇坂 明美 ID: 9000254442054

    北海道大学医学部第一病理 (1994 from CiNii)

    Articles in CiNii:1

    • Blood group antigens and their genetic analysis.3 HLA.Recent HLA classification and its significance. (1994)
  • 脇坂 明美 ID: 9000267831981

    Articles in CiNii:1

    • 諸外国におけるHBIG製剤原料血漿の確保 (2014)
  • 脇坂 明美 ID: 9000347298148

    北海道大学医学部病理学第一 (1994 from CiNii)

    Articles in CiNii:1

    • HLA-DNAタイピングの導入と血清学的タイピング結果との相違 (1994)
  • Akemi WAKISAKA ID: 1000090113646

    北海道大学第1病理 (1998 from CiNii)

    Articles in CiNii:21

    • The Usefulness of HLA-DNA Typing-The Study in Using Commercially Sold Kits- (1995)
    • The pathology of the islets of Langerhans in young onset insulin-dependent diabetes mellitus. (1995)
    • HLAと疾患の相関の最近の知見--分子生物学はどこまで明らかにしたか (1989)
  • WAKISAKA AKEMI ID: 9000254733692

    <I>Department of Pathology, Hokkaido University School of Medicine</I> (1980 from CiNii)

    Articles in CiNii:1

    • ANTIBODY RESPONSE FOLLOWING RUBELLA IMMUNIZATION ANALYZED BY HLA TYPES (1980)
  • WAKISAKA Akemi ID: 9000000767506

    Japanese Red Cross Plasma Fractionation Center (2002 from CiNii)

    Articles in CiNii:6

    • 高純度濃縮第 VIII 因子製剤 "クロスエイト M" の第 VIII 因子活性について (1999)
    • EFFICIENT VIRAL SCREENING SYSTEM BY NUCLEIC ACID AMPLIFICATION TECHNOLOGY (NAT) : Evaluation of automatic extraction system GT-12 in HCV RNA testing (1999)
    • RHA SCREENING AND REDUCTION OF PARVOVIRUS B19 DNA FROM FACTOR VIII CONCENTRATE (CROSS EIGHT M^<TM>) (2002)
  • WAKISAKA Akemi ID: 9000020673007

    First Departments of Pathology, Hokkaido University (1991 from CiNii)

    Articles in CiNii:1

    • Primitive Neuroectodermal Tumor with Wilms' Tumor:Case Report (1991)
  • Wakisaka Akemi ID: 9000254053356

    Japanese Red Cross Plasma Fractionation Center (1999 from CiNii)

    Articles in CiNii:1

    • Viral Safety of Plasma-derived Blood Products. III. Effects of Virus Inactivation by Pasteurization in Human Serum Albumin Concentrates (Sekijyuji Albumin and Sekijyuji Albumin 25).:III. Effects of Virus Inactivation by Pasteurization in Human Serum Albumin Concentrates (Sekijyuji Albumin<sup>®</sup> and Sekijyuji Albumin 25<sup>®</sup>) (1999)
  • Wakisaka Akemi ID: 9000254053365

    Japanese Red Cross Plasma Fractionation Center (1999 from CiNii)

    Articles in CiNii:1

    • Viral Safety of Plasma-derived Blood Products. II. Effect of Virus Elimination by Nanofiltration Using PLANOVA35N on Monoclonalpurified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M) and Intramascular Human Immunoglobulin (Anti-HBs Human immune Globulin "Nisseki" and Human Immune Globulin "Nisseki").:II. Effect of Virus Elimination by Nanofiltration Using PLANOVA 35 N on Monoclonal-purified Freeze-Dried Coagulation Factor VIII Concentrate (CROSS EIGHT M<sup>®</sup>) and Intramascular Human Imm (1999)
  • Wakisaka Akemi ID: 9000254053374

    Japanese Red Cross Plasma Fractionation Center (1999 from CiNii)

    Articles in CiNii:1

    • Viral Safety of Plasma-derived Blood Products. I. Efficiency of Virus Inactivation/Elimination during Manufacturing Process of Monoclonal Antibody-purified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M).:I. Efficiency of Virus Inactivation/Elimination during Manufacturing Process of Monoclonal Antibody-purified Freeze-Dried Coagulation Factor VIII Concentrate (CROSS EIGHT M<sup>®</sup>) (1999)
  • Wakisaka Akemi ID: 9000254053521

    Japanese Red Cross Plasma Fractionation Center (2002 from CiNii)

    Articles in CiNii:1

    • RHA screening and reduction of parvovirus B19 DNA from factor VIII concentrate (cross eight M). (2002)
  • Wakisaka Akemi ID: 9000254442873

    Japanese Red Cross Plasma Fractionation Center (1999 from CiNii)

    Articles in CiNii:1

    • Efficient Viral Screening System by Nucleic Acid Amplification Technology (NAT). Evaluation of Automatic Extraction System GT-12 in HCV RNA Testing.:Evaluation of automatic extraction system GT-12 in HCV RNA testing (1999)
  • Wakisaka Akemi ID: 9000256592044

    First Departmet of Pathology, Hokkaido University School of Medicine (1985 from CiNii)

    Articles in CiNii:1

    • Islet cell antibodies, HLA antigens and thyroid autoantibodies in children with IDDM. (1985)
  • Wakisaka Akemi ID: 9000256864931

    The First Department of Pathology, School of Medicine, Hokkaido University (1994 from CiNii)

    Articles in CiNii:1

    • Vasospastic angina and coronary spasm in siblings in two families:Association of genetic factor with coronary vasospasm (1994)
  • Wakisaka Akemi ID: 9000375859453

    Japan Blood Products Organization (2017 from CiNii)

    Articles in CiNii:1

    • Evidence-based Guidelines for the Use of Albumin Products Japan Society of Transfusion Medicine and Cell Therapy (2017)
Page Top